Compare Kalbe Farma Tbk (KLBF) vs Reksa Dana Indeks Mandiri ETF Sri-Kehati (XMSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kalbe Farma Tbk vs Reksa Dana Indeks Mandiri ETF Sri-Kehati — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Reksa Dana Indeks Mandiri ETF Sri-Kehati trades at Rp332 (market cap 48.64B). The key difference: Kalbe Farma Tbk is far larger — about 678.5× Reksa Dana Indeks Mandiri ETF Sri-Kehati's market cap. Which is the better fit depends on your goals.
| KLBF | XMSK | |
|---|---|---|
Market Cap | 33T | 48.64B |
Volume | 98.44M | — |
Lot | 984.38K | — |
Turnover | 70.64B | — |
Average Price | 717.58 | — |
Value | 70.64B | — |
Indicative Equilibrium Price | 720 | — |
Indicative Equilibrium Volume | 43.62K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kalbe Farma Tbk
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →
